21
Participants
Start Date
September 13, 2016
Primary Completion Date
December 18, 2024
Study Completion Date
December 20, 2025
Anti-ICOS Monoclonal Antibody MEDI-570
Given IV
Laboratory Biomarker Analysis
Correlative studies
Pharmacological Study
Correlative studies
Montefiore Medical Center-Einstein Campus, The Bronx
Montefiore Medical Center-Weiler Hospital, The Bronx
Montefiore Medical Center - Moses Campus, The Bronx
Roswell Park Cancer Institute, Buffalo
Duke University Medical Center, Durham
Moffitt Cancer Center, Tampa
University of Kentucky/Markey Cancer Center, Lexington
Ohio State University Comprehensive Cancer Center, Columbus
University of Chicago Comprehensive Cancer Center, Chicago
Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
Siteman Cancer Center at West County Hospital, Creve Coeur
University of Kansas Clinical Research Center, Fairway
University of Nebraska Medical Center, Omaha
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Huntsman Cancer Institute/University of Utah, Salt Lake City
City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento
Smilow Cancer Center/Yale-New Haven Hospital, New Haven
Yale University, New Haven
BCCA-Vancouver Cancer Centre, Vancouver
University Health Network-Princess Margaret Hospital, Toronto
National Cancer Institute (NCI)
NIH